Results 161 to 170 of about 9,230,509 (381)

Laminar neuropathology in Alzheimer's disease by a modified Gallyas impregnation [PDF]

, 1989
Helmut Heinsen, H. Beckmann, Y. L. Heinsen, Ferenc Gallyas, Silke Haas, G. Scharff   +5 more
openalex   +1 more source

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

Alzheimer's & Dementia, 2011
M. Albert, S. DeKosky, D. Dickson, B. Dubois, H. Feldman, Nick C Fox, A. Gamst, D. Holtzman, W. Jagust, R. Petersen, P. Snyder, M. Carrillo, B. Thies, C. Phelps   +13 more
semanticscholar   +1 more source

2024 Alzheimer's disease facts and figures

Alzheimer's & Dementia
This article describes the public health impact of Alzheimer's disease (AD), including prevalence and incidence, mortality and morbidity, use and costs of care and the ramifications of AD for family caregivers, the dementia workforce and society.

semanticscholar   +1 more source

Structure‐Guided Engineering of Oleate Hydratase for the Synthesis of Small Chiral Alcohols without Decoy Molecule

Advanced Synthesis &Catalysis, EarlyView.
Abstract Small and chiral secondary alcohols are sought‐after compounds that are frequently used in the synthesis of biologically active compounds. However, their stereochemically correct synthesis remains a challenge for the chemical industry. Synthetic routes are restrained by multiple steps and thus low atom efficiency.
Natalie Härterich, Andreas Schneider, Philip Horz, Nicolas D. Travnicek, Bernhard Hauer   +4 more
wiley   +1 more source

A pilot randomized controlled trial of WeiNaoKang (SaiLuoTong) in treating vascular dementia

AGING MEDICINE, Volume 5, Issue 4, Page 246-256, December 2022., 2022
A 16‐week randomized double‐blind, placebo‐controlled trial for vascular dementia was carried out with WeiNaoKang (or SaiLuoTong). There were significant differences in improvement in cognitive function and activities of daily living, favouring the treatment group.
Junguang Liu, Dennis Chang, Dennis Cordato, Kien Lee, Hugh Dixson, Alan Bensoussan, Daniel Kam Yin Chan   +6 more
wiley   +1 more source

Fatty acid composition of brain glycolipids in Alzheimer's disease, senile dementia, and cerebrocortical atrophy

, 1968
George D. Cherayil
openalex   +1 more source

Picomolar Detection of Tau Protein Using 1D Photonic Crystal Biochips for Alzheimer's Disease Diagnosis

Advanced Sensor Research, EarlyView.
Elevated levels of Tau in cerebrospinal fluids or other body fluids are associated with the progression of Alzheimer's disease. An optical technique, based on a dual label‐free and fluorescence operation mode, is developed to detect Tau protein in both standard running buffer and cerebrospinal fluid.
Alberto Sinibaldi, Francesco Chiavaioli, Agostino Occhicone, Norbert Danz, Peter Munzert, Francesco Baldini, Ambra Giannetti, Francesco Michelotti   +7 more
wiley   +1 more source

Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials

Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 2023
Christopher H. Van Dyck, Ryan S. O'Dell, Adam P. Mecca   +2 more
doaj   +1 more source

Sialylated Human Apolipoprotein E (apoEs) Is Preferentially Associated with Neuron-Enriched Cultures from APOE Transgenic Mice

Neurobiology of Disease, 1999
Mice transgenic for human APOE2, E3, and E4 alleles express native 34-kDa human apoE and two sialylated apoE isoproteins with approximate molecular weights of 37 kDa (apoEs) and 39 kDa (apoEs2) in brain.
Pu-Ting Xu, Donald Schmechel, Hui-Ling Qiu, Michael Herbstreith, Tracie Rothrock-Christian, Michele Eyster, Allen D. Roses, John R. Gilbert   +7 more
doaj  

ALZHEIMER'S DISEASE: A CASE REPORT WITH CEREBRAL BIOPSY AND ENYMATIC-HISTOCHEMICAL OBSERVATIONS

, 1963
Tadashi Miyake, K Torizuka, Hiroshi Nishitani, Shigeru Matsukura, Hiroshi Tazawa, Tadashi Suzuki, I Miyoshi   +6 more
openalex   +2 more sources